{"SPADE_UN_17170": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17170", "Peptide Name": "cyclic [W(RW)4]", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "WRWKKKKA", "Sequence Length": 8, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Cyclic", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C55H87N17O9", "Mass": 1130.39, "PI": 11.33, "Net Charge": 5, "Hydrophobicity": -2.51, "Half Life": "Mammalian:2.8 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs.", "Pubmed ID": "23301519", "Reference": "Mol Pharm. 2013 Feb 4;10(2)488-100.", "Author": "Nasrolahi Shirazi A, Tiwari R, Chhikara BS, Mandal D, Parang K.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=23301519"}], "Frequent Amino Acids": "KWA", "Absent Amino Acids": "CDEFGHILMNOPQSTUVY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 3, "Polar Residues": 6, "Positive Residues": 5, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_11398", "Similarity": 1.0, "Sequence": "WRWKWRWK"}, {"SPADE_ID": "SPADE_N_12220", "Similarity": 1.0, "Sequence": "YKARRWAWRWK"}, {"SPADE_ID": "SPADE_N_12221", "Similarity": 1.0, "Sequence": "YKAWRWAWRWK"}]}}}